Lupin Limited header image

Lupin Limited

500257

Equity

ISIN INE326A01037 / Valor 11598960

Bombay Stock Exchange Ltd. (Mumbai) (2026-11-13)
INR 1,980.00-1.69%

Lupin Limited
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Lupin Limited is an Indian multinational pharmaceutical company, founded in 1968 and headquartered in Mumbai, that researches, develops, manufactures and markets a portfolio of branded and generic medicines and active pharmaceutical ingredients (APIs). Its products span major therapeutic areas such as cardiovascular, diabetes, respiratory, central nervous system, anti‑infectives and gastrointestinal treatments, and the company supplies oral solids, injectables and specialty dosage forms to wholesalers, hospitals and retail markets. Lupin has a significant presence in India and the United States and maintains manufacturing and R&D operations in multiple countries, while also investing in specialty generics, biosimilars and novel drug-delivery technologies to support its global product pipeline.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-3.55%1Y
68.8%3Y
109%5Y

Performance

20.1%1Y
25.1%3Y
26.4%5Y

Volatility

Market cap

9642 M

Market cap (USD)

Daily traded volume (Shares)

12,670

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Neumora Therapeutics Inc
Neumora Therapeutics Inc Neumora Therapeutics Inc Valor: 129329732
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%USD 0.43
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.44%CHF 404.70
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203211
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.91%CHF 412.00
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.30%CHF 79.55
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.06%CHF 3.91
Siegfried Holding Ltd
Siegfried Holding Ltd Siegfried Holding Ltd Valor: 1428449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.40%CHF 70.25
AEVIS VICTORIA SA
AEVIS VICTORIA SA AEVIS VICTORIA SA Valor: 47863410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 14.15
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.03%CHF 8.65
UCB SA
UCB SA UCB SA Valor: 986410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.44%EUR 296.50
Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 24.20